Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
D000200:Action Potentials / Q000187:drug effects; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000009:adverse effects; D004285:Dogs; D006329:Heart Conduction System / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D008012:Lidocaine / Q000494:pharmacology*; D008564:Membrane Potentials / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology*; D010210:Papillary Muscles; D011433:Propranolol / Q000494:pharmacology*; D013015:Sotalol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D013565:Sympatholytics; D010042:Ouabain; D008012:Lidocaine; D011433:Propranolol; D013015:Sotalol